AI is beginning to find its place in BD&L. While adoption varies across companies, many BD teams are already experimenting with AI to speed up search, landscape monitoring and early-stage analysis. Yet questions remain about where AI truly adds value and where traditional methods still outperform the technology.
Watch this 45-minute recorded webinar (10 February 2026) with CELforPharma faculty member Dr Carlos Velez.
📢 Coming soon: The AI for BD&L Course (with Dr Carlos Velez)
A new course designed for Business Development & Licensing professionals who want to understand how AI is changing the way deals are sourced, evaluated, and structured. Be the first to know when dates are confirmed: Keep me informed >
Continue your learning from Dr Carlos Velez
If you’d like to learn more from Dr Carlos Velez, CELforPharma also offers a 2-day, hands-on course where you will:
- Gain a clear end-to-end view of BD&L in pharma and biotech
- Understand in-licensing and out-licensing planning and execution
- Learn the basics of valuation, IP, term sheets, and negotiation
- Work through case studies and group exercises grounded in real practice
Business Development & Licensing Course For Pharma & Biotech
With Dr Carlos Velez
Don’t miss future CELforPharma webinars
Subscribe to our newsletter to:
- Receive invitations to upcoming educational webinars
- Stay on top of the latest expert insights
- Get updates on our courses and training programmes